MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2

Guangfeng Niu1, Bin Li1, Li Sun1

  • 1Department of Orthopaedics, Shandong Provincial Hospital affiliated to Shandong University, Shandong University, Jinan, P.R. China.

Plos One
|March 21, 2015
PubMed

Insights

MicroRNA-153 (miR-153) acts as a tumor suppressor in osteosarcoma. This study found miR-153 inhibits osteosarcoma cell proliferation and invasion by targeting transforming growth factor beta 2 (TGF-β2).

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs crucial for cellular processes.
  • Aberrant miRNA expression is linked to cancer development and progression.
  • miRNAs offer potential for cancer mechanism understanding and novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of miR-153 in human osteosarcoma.
  • To identify the molecular targets and pathways regulated by miR-153 in osteosarcoma cells.

Main Methods:

  • Quantitative real-time PCR to assess miR-153 expression in osteosarcoma tissues and cell lines.
  • Transfection of miR-153 mimics into MG-63 osteosarcoma cells.
  • Western blotting to analyze the expression of downstream signaling molecules.
  • Cell proliferation and migration assays.

Main Results:

  • miR-153 was significantly downregulated in human osteosarcoma tissues and cell lines.
  • Overexpression of miR-153 inhibited MG-63 cell proliferation and invasion.
  • miR-153 directly targeted and negatively regulated transforming growth factor beta 2 (TGF-β2).
  • miR-153 overexpression reduced the expression of TGF-β signaling pathway components (p-SMAD2, p-SMAD3, EGFR, IGFBP-3).

Conclusions:

  • miR-153 functions as a tumor suppressor in osteosarcoma.
  • The tumor-suppressive role of miR-153 is mediated through the inhibition of the TGF-β2 signaling pathway.
  • miR-153 represents a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K